DOI: 10.36347/sjmcr.2023.v11i04.001

Pages: 419-425

Cerebral venous thrombosis or cerebral thrombophlebitis is rare forms of cerebrovascular accidents that affect the venous sinuses and/or cerebral veins. These thromboses are responsible for an obstacle to cerebral venous return and cause suffering of the cerebral parenchyma, ranging from isolated intracranial hypertension (ICHT) to ischemia or parenchymal hemorrhage. It is a rare but serious pathology with an estimated incidence of 5 to 6 cases per million inhabitants. They are characterized by their great diversity in etiology and clinical presentation with a polymorphic and misleading symptomatology. Thanks to the development of neuroradiological means, the positive diagnosis of cerebral thrombophlebitis has progressed spectacularly. Cerebral CT is the tool of first choice. MRI, when available, remains the examination of choice for the diagnosis of CVT. The initiation of anti-coagulant treatment associated with the treatment of HTIC is the mainstay of treatment. The early treatment of CVT is no longer a pathology with a fatal outcome nowadays, with a clear reduction in morbi-mortality. The objective of our work is to describe the epidemiological, clinical, paraclinical, therapeutic and evolutionary characteristics through a retrospective study over a period of 2 years from January 2021 to December 2022, including all patients admitted to the in the intensive Care Department A1 of the Hassan II University Hospital of Fez for the management of CT.